top of page


FDA approves Edwards Lifesciences Pascal Precision system for tricuspid valve repair
The FDA has approved Edwards Lifesciences' Pascal Precision system for transcatheter repair of severe tricuspid regurgitation, expanding the device's use beyond mitral valve treatment.

nuaxia
Oct 222 min read


Jaguar LAA acquires Johnson & Johnson Laminar assets for atrial fibrillation programme
Jaguar LAA has acquired assets from Johnson & Johnson related to the Laminar left atrial appendage closure programme, creating a newly independent medical-device company focused on advancing the technology.

nuaxia
Sep 152 min read
bottom of page